Catalyst Pharmaceutical Partners, Inc. (NASDAQ: CPRX) is a company who develops therapeutic solutions ... reiterating an overweight rating on the stock and boosting his price target from $5 to $7. Following Catalyst’s discussion with the …
AERI closed Wednesday's trading at $14.84, up 6.46%. In after hours, the stock was up 16.58% to $17.30. Shares of Catalyst Pharmaceuticals Inc. (CPRX) plunged 37% on Wednesday after the company's New Drug Application for …
MIAMI, FL / ACCESSWIRE / April 29, 2016 / Daily Stock Reporter is issuing a report on four stocks to watch. FREEF, KEG, CPRX, and HUSA have been added to our watch list today. Continue reading to find out why. – To get daily alerts …
The stock decreased 1.61% or $0.05 on July 28, reaching $3.05. About 520,974 shares traded. Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) has risen 267.48% since July 29, 2016 and is uptrending. It has outperformed by 250.78% the …
CLDX was an $11 stock two months ago when I bought shares and noted so on ... The star performer on Friday, is the smallest/cheapest of the speculative buys that I have — Catalyst Pharma (CPRX) that was up 10.16% to $1.03. Very …
CORAL GABLES, Fla., Sept. 5, 2013 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) announced today that it has entered into definitive agreements to sell 8.8 million shares of its common stock in a …
Access a Zacks stock report on CPRX at https://www.zacks.com/ap/CPRX Keywords: Catalyst Pharmaceutical, Earnings Report Powered and implemented by Interactive Data Managed Solutions News provided by The Associated Press.
Recently analysts working for various investment brokerages have changed their ratings and price targets on shares of Catalyst Pharmaceutical Partners, Inc. (CPRX). According to ... have a USD 6 price target on the stock. 10/13/2016 …